PUNCTURE SITE INJURY

PUNCTURE SITE INJURY was reported 25 times

These drug classes are most commonly taken by patients reporting PUNCTURE SITE INJURY:

# Drug Count
0 Copper-containing Intrauterine Device [EPC] 2
1 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2
2 Interleukin-17A Antagonist [EPC] 2
3 Interleukin-6 Receptor Antagonist [EPC] 2
4 PCSK9 Inhibitor [EPC] 2
5 Standardized Chemical Allergen [EPC] 2
6 Tumor Necrosis Factor Blocker [EPC] 2
7 Acetylcholine Release Inhibitor [EPC] 1
8 Antisense Oligonucleotide [EPC] 1
9 Aromatase Inhibitor [EPC] 1
10 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
11 Benzodiazepine [EPC] 1
12 Calcium [EPC] 1
13 Catecholamine [EPC] 1
14 Cholinergic Muscarinic Antagonist [EPC] 1
15 Corticosteroid [EPC] 1
16 Echinocandin Antifungal [EPC] 1
17 Factor Xa Inhibitor [EPC] 1
18 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
19 Interferon beta [EPC] 1
20 Interleukin-23 Antagonist [EPC] 1
21 Interleukin-4 Receptor alpha Antagonist [EPC] 1
22 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
23 Janus Kinase Inhibitor [EPC] 1
24 Loop Diuretic [EPC] 1
25 Neuromuscular Blocker [EPC] 1
26 Non-Standardized Chemical Allergen [EPC] 1
27 Non-Standardized Food Allergenic Extract [EPC] 1
28 Non-Standardized Fungal Allergenic Extract [EPC] 1
29 Non-Standardized Insect Allergenic Extract [EPC] 1
30 Non-Standardized Plant Allergenic Extract [EPC] 1
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1
32 Provitamin D2 Compound [EPC] 1
33 Standardized Insect Venom Allergenic Extract [EPC] 1
34 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
35 Thiazide Diuretic [EPC] 1
36 alpha-Adrenergic Agonist [EPC] 1
37 beta-Adrenergic Agonist [EPC] 1
38 beta3-Adrenergic Agonist [EPC] 1